NEUKF - $2.5M USD Private Equity Investment

The following appears as a matter of record only

 

 

Neurokine Pharmaceuticals Inc.
(NEUKF)

 

$2.5M USD Private Equity Investment
(Term Sheet Facilitated)

 

The undersigned is pleased to announce that
it has facilitated an institutional private investment
for the purpose of working capital

 

Neurokine Pharmaceuticals Inc. (“Neurokine”) a publicly traded company (OTCBB: NEUKF) incorporated in 2002 in British Columbia and formerly known as “Xerxes Health Corp.”. Neurokine Pharmaceuticals Inc. is a development stage biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceutical products, with a strategic emphasis on the innovation of new therapeutic uses for existing drugs. This is commonly known as drug re-profiling.

06
Feb
posted in: Tombstones by

Leave a Reply

*